News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alcon, Inc. (ACL) Announces Shareholder Meeting to Effect Previously Agreed Conditional Replacement of Nestle SA-Nominated Directors


7/1/2010 12:12:09 PM

HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE:ACL) (“Alcon”) announced today that the Alcon board of directors resolved to hold an extraordinary general meeting of the Alcon shareholders, to be held on August 16, 2010 in Zug, Switzerland. The purpose of the meeting is to hold a shareholder vote on the conditional election of directors nominated by Novartis AG (“Novartis”) to replace directors nominated by Nestlé S.A. (“Nestlé”) if and when Novartis acquires Nestlé’s remaining shares of Alcon. The directors nominated by Novartis and standing for election are:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES